Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Loading…
Loading…
Human Laboratory Studies on Cannabinoids and Psychosis
Sherif, Mohamed, Radhakrishnan, Rajiv, D’Souza, Deepak Cyril, Ranganathan, Mohini
Published in Biological psychiatry (1969) (01.04.2016)
Published in Biological psychiatry (1969) (01.04.2016)
Get full text
Journal Article
Loading…
Loading…
Impaired functional connectivity of brain reward circuitry in patients with schizophrenia and cannabis use disorder: Effects of cannabis and THC
Fischer, Adina S., Whitfield-Gabrieli, Susan, Roth, Robert M., Brunette, Mary F., Green, Alan I.
Published in Schizophrenia research (01.09.2014)
Published in Schizophrenia research (01.09.2014)
Get full text
Journal Article
Loading…
Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios
Englund, Amir, Oliver, Dominic, Chesney, Edward, Chester, Lucy, Wilson, Jack, Sovi, Simina, De Micheli, Andrea, Hodsoll, John, Fusar-Poli, Paolo, Strang, John, Murray, Robin M., Freeman, Tom P., McGuire, Philip
Published in Neuropsychopharmacology (New York, N.Y.) (01.05.2023)
Published in Neuropsychopharmacology (New York, N.Y.) (01.05.2023)
Get full text
Journal Article
Loading…
Cannabinoid receptor 2 agonist, lenabasum, for the treatment of pulmonary exacerbations in cystic fibrosis
West, Natalie E., Konstan, Michael W., Flume, Patrick A., VanDevanter, Donald R., Magaret, Amalia, Mazurek, Henryk, Amelina, Elena L., Laki, István, Chiron, Raphael, Sutharsan, Sivagurunathan, Columbo, Carla, Dorkin, Henry L., Downey, Damian G., Sole, Amparo, Hjelte, Lena, Tullis, Elizabeth, Dgetluck, Nancy, Dinh, Quinn, Constantine, Scott, White, Barbara, Elborn, J. Stuart, Chmiel, James F.
Published in Journal of cystic fibrosis (01.07.2025)
Published in Journal of cystic fibrosis (01.07.2025)
Get full text
Journal Article
Loading…
Anti-allodynic and medullary modulatory effects of a single dose of delta-9-tetrahydrocannabinol (THC) in neuropathic rats tolerant to morphine
Pearl-Dowler, Leora, Posa, Luca, Lopez-Canul, Martha, Teggin, Alexandra, Gobbi, Gabriella
Published in Progress in neuro-psychopharmacology & biological psychiatry (20.12.2023)
Published in Progress in neuro-psychopharmacology & biological psychiatry (20.12.2023)
Get full text
Journal Article
Loading…
Cannabinoid modulation of prefrontal–limbic activation during fear extinction learning and recall in humans
Rabinak, Christine A., Angstadt, Mike, Lyons, Maryssa, Mori, Shoko, Milad, Mohammed R., Liberzon, Israel, Luan Phan, K.
Published in Neurobiology of learning and memory (01.09.2014)
Published in Neurobiology of learning and memory (01.09.2014)
Get full text
Journal Article
Loading…
Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical Trial
Werth, Victoria P., Hejazi, Emily, Pena, Sandra M., Haber, Jessica, Zeidi, Majid, Reddy, Nithin, Okawa, Joyce, Feng, Rui, Bashir, Muhammad M., Gebre, Kirubel, Jadoo, Arvin S., Concha, Josef Symon S., Dgetluck, Nancy, Constantine, Scott, White, Barbara
Published in Journal of investigative dermatology (01.10.2022)
Published in Journal of investigative dermatology (01.10.2022)
Get full text
Journal Article
Loading…
Cannabinoid modulation of opioid analgesia and subjective drug effects in healthy humans
Babalonis, Shanna, Lofwall, Michelle R., Sloan, Paul A., Nuzzo, Paul A., Fanucchi, Laura C., Walsh, Sharon L.
Published in Psychopharmacology (01.11.2019)
Published in Psychopharmacology (01.11.2019)
Get full text
Journal Article
Loading…
Delta‐8 tetrahydrocannabinol: a scoping review and commentary
LoParco, Cassidy R., Rossheim, Matthew E., Walters, Scott T., Zhou, Zhengyang, Olsson, Sofia, Sussman, Steve Y.
Published in Addiction (Abingdon, England) (01.06.2023)
Published in Addiction (Abingdon, England) (01.06.2023)
Get full text
Journal Article
Loading…
Loading…
Potent immunomodulatory activity of a highly selective cannabinoid CB2 agonist on immune cells from healthy subjects and patients with multiple sclerosis
Annunziata, Pasquale, Cioni, Chiara, Mugnaini, Claudia, Corelli, Federico
Published in Journal of neuroimmunology (15.02.2017)
Published in Journal of neuroimmunology (15.02.2017)
Get full text
Journal Article
Loading…
Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence
Slivicki, Richard A., Xu, Zhili, Kulkarni, Pushkar M., Pertwee, Roger G., Mackie, Ken, Thakur, Ganesh A., Hohmann, Andrea G.
Published in Biological psychiatry (1969) (15.11.2018)
Published in Biological psychiatry (1969) (15.11.2018)
Get full text
Journal Article
Loading…
Loading…
Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor
Khajehali, Elham, Malone, Daniel T., Glass, Michelle, Sexton, Patrick M., Christopoulos, Arthur, Leach, Katie
Published in Molecular pharmacology (01.08.2015)
Published in Molecular pharmacology (01.08.2015)
Get full text
Journal Article
Loading…
Cannabinoid-Induced Hyperphagia is Mediated by Increased Meal Frequency and the Orexin-1 Receptor in Male Rats
Lord, Magen N, Madu, Grace C, Loera-Lopez, Ana L, Aaron, Alexander P, Lin, Jessica, Noble, Emily E
Published in Pharmacology research & perspectives (01.10.2025)
Published in Pharmacology research & perspectives (01.10.2025)
Get full text
Journal Article
Loading…
Cannabinoid CB2 Receptor Gene and Environmental Interaction in the Development of Psychiatric Disorders
Ishiguro, Hiroki, Horiuchi, Yasue, Tabata, Koichi, Liu, Qing-Rong, Arinami, Tadao, Onaivi, Emmanuel S.
Published in Molecules (24.07.2018)
Published in Molecules (24.07.2018)
Get full text
Journal Article
Loading…